Literature DB >> 15756757

Natalizumab.

John H Noseworthy, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15756757     DOI： 10.1038/nrd1637

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  4 in total

1.  Selective induction of cell adhesion molecules by proinflammatory mediators in human cardiac microvascular endothelial cells in culture.

Authors:  Jun Yan; Adrian D Nunn; Regi Thomas
Journal:  Int J Clin Exp Med       Date:  2010-10-23

Review 2.  Influence of integrins on thrombus formation: a road leading to the unravelling of DVT.

Authors:  Nilanjana Ghosh; Iti Garg; Swati Srivastava; Bhuvnesh Kumar
Journal:  Mol Cell Biochem       Date:  2021-01-04       Impact factor: 3.396

Review 3.  Therapeutic anti-integrin (alpha4 and alphaL) monoclonal antibodies: two-edged swords?

Authors:  Roberto González-Amaro; María Mittelbrunn; Francisco Sánchez-Madrid
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

4.  Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

Authors:  Carl E Reid; Huo Li; Gargi Sur; Paul Carmillo; Steven Bushnell; Rich Tizard; Michele McAuliffe; Christopher Tonkin; Kenneth Simon; Susan Goelz; Paola Cinque; Leonid Gorelik; John P Carulli
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.